The methylglyoxal-derived AGE tetrahydropyrimidine is increased in plasma of individuals with type 1 diabetes mellitus and in atherosclerotic lesions and is associated with sVCAM-1
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Aims/hypothesis Methylglyoxal (MGO) is a major precursor for advanced glycation end-products (AGEs), which are thought to play a role in vascular complications in diabetes. Known MGO-arginine-derived AGEs are 5-hydro-5-methylimidazolone (MG-H1), argpyrimidine and tetrahydropyrimidine (THP). We studied THP in relation to type 1 diabetes, endothelial dysfunction, low-grade inflammation, vascular complications and atherosclerosis.Methods We raised and characterised a monoclonal antibody against MGO-derived THP. We measured plasma THP with a competitive ELISA in two cohort studies: study A (198 individuals with type 1 diabetes and 197 controls); study B (individuals with type 1 diabetes, 175 with normoalbuminuria and 198 with macroalbuminuria [>300 mg/24 h]). We measured plasma markers of endothelial dysfunction and low-grade inflammation, and evaluated the presence of THP and N (ε)-(carboxymethyl)lysine (CML) in atherosclerotic arteries.Results THP was higher in individuals with type 1 diabetes than in those without (median [interquartile range] 115.5 U/μl [102.4-133.2] and 109.8 U/μl [91.8-122.3], respectively; p = 0.03). THP was associated with plasma soluble vascular cell adhesion molecule 1 in both study A (standardised β = 0.48 [95% CI 0.38, 0.58]; p < 0.001) and study B (standardised β = 0.31 [95% CI 0.23, 0.40]; p < 0.001), and with secreted phospholipase A2 (standardised β = 0.26 [95% CI 0.17, 0.36]; p < 0.001) in study B. We found no association of THP with micro- or macro-vascular complications. Both THP and CML were detected in atherosclerotic arteries.Conclusions/interpretation Our results suggest that MGO-derived THP may reflect endothelial dysfunction among individuals with and without type 1 diabetes, and therefore may potentially play a role in the development of atherosclerosis and vascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The studies derived from these techniques evidence a net increased AGEs level in obesity [187], Diabetes Mellitus [207] and chronic inflammatory diseases, like Rheumatoid Arthritis [208], as well as in age-related diseases, such as cardiovascular, renal and neurodegenerative pathologies [193,209].”
From GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review (2022) · cites this paper as [207]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Schmidt, A. M., Hori, O., Chen, J. X., Li, J. F., Crandall, J., Zhang, J., Cao, R., Yan, S. D., Brett, J., & Stern, D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118175 · Cited by 896 · cited 1×
“This is consistent with experiments that demonstrated that AGEs are able to induce the expression of sVCAM-1 [28, 29].”
ResultO'Brien, K. D., Allen, M. D., McDonald, T. O., Chait, A., Harlan, J. M., Fishbein, D., McCarty, J., Ferguson, M., Hudkins, K., & Benjamin, C. D. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116670 · Cited by 703
Glyoxalase System in Clinical Diabetes Mellitus and Correlation with Diabetic Complications
McLellan, A. C., Thornalley, P. J., Benn, J., & Sonksen, P. H. (1994) · Clinical Science · doi:10.1042/cs0870021 · Cited by 557
The glyoxalase system in health and disease
Thornalley, P. J. (1993) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(93)90002-u · Cited by 533
Shinohara, M., Thornalley, P. J., Giardino, I., Beisswenger, P., Thorpe, S. R., Onorato, J., & Brownlee, M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119885 · Cited by 513
Methylglyoxal Modification of Protein
Oya, T., Hattori, N., Mizuno, Y., Miyata, S., Maeda, S., Osawa, T., & Uchida, K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18492 · Cited by 377
Rosca, M. G., Mustata, T. G., Kinter, M. T., Ozdemir, A. M., Kern, T. S., Szweda, L. I., Brownlee, M., Monnier, V. M., & Weiss, M. F. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00415.2004 · Cited by 354 · cited 2×
“Although these studies [1, 3, 4, 7–10, 14–18] indicate that MGO is involved in the pathophysiology of vascular complications, the formation of MGO-modified proteins and their relationship in the development of complications require further investigation.”
BackgroundResultAHMED, N., ARGIROV, O. K., MINHAS, H. S., CORDEIRO, C. A. A., & THORNALLEY, P. J. (2002) · Biochemical Journal · doi:10.1042/bj3640001 · Cited by 336
Schalkwijk, C. G., Poland, D. C. W., van Dijk, W., Kok, A., Emeis, J. J., Dräger, A. M., Doni, A., van Hinsbergh, V. W. M., & Stehouwer, C. D. A. (1999) · Diabetologia · doi:10.1007/s001250051162 · Cited by 309
Self-citationMethylglyoxal-Derived Hydroimidazolone Advanced Glycation End-Products of Human Lens Proteins
Ahmed, N., Thornalley, P. J., Dawczynski, J., Franke, S., Strobel, J., Stein, G., & Haik, G. M. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.03-0573 · Cited by 282
Glyoxalase in diabetes, obesity and related disorders
Rabbani, N., & Thornalley, P. J. (2011) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2011.02.015 · Cited by 249
Vlassara, H., Fuh, H., Donnelly, T., & Cybulsky, M. (1995) · Molecular Medicine · doi:10.1007/bf03401582 · Cited by 244
Nin, J. W., Jorsal, A., Ferreira, I., Schalkwijk, C. G., Prins, M. H., Parving, H.-H., Tarnow, L., Rossing, P., & Stehouwer, C. D. (2011) · Diabetes Care · doi:10.2337/dc10-1087 · Cited by 242
Self-citationAhmed, N., Babaei-Jadidi, R., Howell, S. K., Beisswenger, P. J., & Thornalley, P. J. (2005) · Diabetologia · doi:10.1007/s00125-005-1810-7 · Cited by 237
Yao, D., Taguchi, T., Matsumura, T., Pestell, R., Edelstein, D., Giardino, I., Suske, G., Rabbani, N., Thornalley, P. J., Sarthy, V. P., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704703200 · Cited by 235
Brouwers, O., Niessen, P. M., Ferreira, I., Miyata, T., Scheffer, P. G., Teerlink, T., Schrauwen, P., Brownlee, M., Stehouwer, C. D., & Schalkwijk, C. G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.144097 · Cited by 229
Self-citationDE JAGER, J., KOOY, A., LEHERT, P., BETS, D., WULFFELÉ, M. G., TEERLINK, T., SCHEFFER, P. G., SCHALKWIJK, C. G., DONKER, A. J. M., & STEHOUWER, C. D. A. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01420.x · Cited by 220
Self-citationPhospholipase A2in Vascular Disease
Hurt-Camejo, E., Camejo, G., Peilot, H., Öörni, K., & Kovanen, P. (2001) · Circulation Research · doi:10.1161/hh1601.095598 · Cited by 219
Brouwers, O., Niessen, P. M., Haenen, G., Miyata, T., Brownlee, M., Stehouwer, C. D., De Mey, J. G., & Schalkwijk, C. G. (2010) · Diabetologia · doi:10.1007/s00125-010-1677-0 · Cited by 192
Self-citationKilhovd, B. K., Giardino, I., Torjesen, P. A., Birkeland, K. I., Berg, T. J., Thornalley, P. J., Brownlee, M., & Hanssen, K. F. (2003) · Metabolism · doi:10.1053/meta.2003.50035 · Cited by 187
Rabbani, N., & Thornalley, P. J. (2008) · Biochemical Society Transactions · doi:10.1042/bst0361045 · Cited by 184
Glowinska, B., Urban, M., Peczynska, J., & Florys, B. (2005) · Metabolism · doi:10.1016/j.metabol.2005.03.004 · Cited by 175
Kilhovd, B. K., Juutilainen, A., Lehto, S., Rönnemaa, T., Torjesen, P. A., Hanssen, K. F., & Laakso, M. (2007) · Diabetologia · doi:10.1007/s00125-007-0687-z · Cited by 165
Clausen, P., Jacobsen, P., Rossing, K., Jensen, J. S., Parving, H. ‐., & Feldt‐Rasmussen, B. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00347.x · Cited by 150
Self-citationRichardson, M., Hadcock, S. J., DeReske, M., & Cybulsky, M. I. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.5.760 · Cited by 150
The effect of type 1 diabetes mellitus on the gender difference in coronary artery calcification
Colhoun, H. M., Rubens, M. B., Underwood, S. R., & Fuller, J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00986-4 · Cited by 142
Self-citationMethylglyoxal-induced mitochondrial dysfunction in vascular smooth muscle cells
Wang, H., Liu, J., & Wu, L. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.02.024 · Cited by 127
Fosmark, D. S., Torjesen, P. A., Kilhovd, B. K., Berg, T. J., Sandvik, L., Hanssen, K. F., Agardh, C., & Agardh, E. (2006) · Metabolism · doi:10.1016/j.metabol.2005.08.017 · Cited by 122
Hegele, J., Buetler, T. M., & Delatour, T. (2008) · Analytica Chimica Acta · doi:10.1016/j.aca.2007.12.027 · Cited by 118
Schalkwijk, C. G., Baidoshvili, A., Stehouwer, C. D. A., van Hinsbergh, V. W. M., & Niessen, H. W. M. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2003.07.002 · Cited by 113
Self-citationThe meaning of serum levels of advanced glycosylation end products in diabetic nephropathy
Shimoike, T., Inoguchi, T., Umeda, F., Nawata, H., Kawano, K., & Ochi, H. (2000) · Metabolism · doi:10.1053/meta.2000.7738 · Cited by 95
Wilker, S. C., Chellan, P., Arnold, B. M., & Nagaraj, R. H. (2001) · Analytical Biochemistry · doi:10.1006/abio.2001.4992 · Cited by 91
Tarnow, L., Cambien, F., Rossing, P. R., Nielsen, F. S., Hansen, B. V., Lecerf, L., Poirier, O., Danilov, S. M., Boelskifte, S., Borch‐Johnsen, K., et al. (1995) · Diabetologia · doi:10.1007/s001250050355 · Cited by 85
Self-citationSoedamah‐Muthu, S. S., Chaturvedi, N., Schalkwijk, C. G., Stehouwer, C. D. A., Ebeling, P., & Fuller, J. (2006) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2005.06.005 · Cited by 85
Self-citationHope, S. A., & Meredith, I. T. (2003) · Internal Medicine Journal · doi:10.1046/j.1445-5994.2003.00379.x · Cited by 82
Soluble Vascular Cell Adhesion Molecule-1 (VCAM-1) as Potential Marker of Atherosclerosis
Weirich, U., Nordt, T. K., Ruef, J., Bode, C., & Peter, K. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615551 · Cited by 72
Klöpfer, A., Spanneberg, R., & Glomb, M. A. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf103116c · Cited by 71
Hirata, K., & Kubo, K. (2004) · Endocrine Journal · doi:10.1507/endocrj.51.537 · Cited by 69
Abordo‐Adesida, E., & Thornalley, P. J. (1997) · Immunology Letters · doi:10.1016/s0165-2478(97)00080-1 · Cited by 66
Westwood, M. E., & Thornalley, P. J. (1996) · Immunology Letters · doi:10.1016/0165-2478(96)02496-0 · Cited by 65
Han, Y., Randell, E. W., Vasdev, S., Gill, V. D., Curran, M., Newhook, L. A., Grant, M., Hagerty, D., & Schneider, C. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2008.12.016 · Cited by 47
Smulders, R. A., Schalkwijk, C. G., Donker, A. J. M., van Hinsbergh, V. W. M., TeKoppele, J. M., & Stehouwer, C. D. A. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615138 · Cited by 40
Self-citationBrock, J. W. C., Cotham, W. E., Thorpe, S. R., Baynes, J. W., & Ames, J. M. (2007) · Journal of Mass Spectrometry · doi:10.1002/jms.1144 · Cited by 40
Lieuw-a-Fa, M., Engelse, M., van Hinsbergh, V., & Schalkwijk, C. (2006) · Thrombosis and Haemostasis · doi:10.1160/th05-04-0248 · Cited by 32
Self-citationPentosidine – A New Biochemical Marker in Diabetic Retinopathy
Salman, A. G., Mansour, D. E. A. A., Swelem, A. H. A. M., El-Zawahry, W. M. A. E. R., & Radwan, A. A. (2009) · Ophthalmic Research · doi:10.1159/000225661 · Cited by 30
Type II secretory phospholipase A2: The emerging role of biochemical markers of plaque inflammation
Piek, J. J., & de Winter, R. J. (2003) · European Heart Journal · doi:10.1016/j.ehj.2003.08.008 · Cited by 7
A novel monoclonal antibody against methylglyoxal–arginine adduct
Oya‐Ito, T., Kawakishi, S., Shibata, N., Kobayashi, M., Osawa, T., & Uchida, K. (2002) · International Congress Series · doi:10.1016/s0531-5131(02)00930-5 · Cited by 3
Cited by
Schalkwijk, C. G., & Stehouwer, C. D. A. (2020) · Physiological Reviews · doi:10.1152/physrev.00001.2019 · Cited by 622
Self-citationThe role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases
Maessen, D. E. M., Stehouwer, C. D. A., & Schalkwijk, C. G. (2015) · Clinical Science · doi:10.1042/cs20140683 · Cited by 334
Self-citationBrings, S., Fleming, T., Freichel, M., Muckenthaler, M., Herzig, S., & Nawroth, P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18050984 · Cited by 204
“Protein bound AGEs and AGE free adducts are increased in experimental models of diabetes [18,39,65], and in diabetic patients in parallel with their precursors [66,67].”
BackgroundHanssen, N. M. J., Beulens, J. W. J., van Dieren, S., Scheijen, J. L. J. M., van der A, D. L., Spijkerman, A. M. W., van der Schouw, Y. T., Stehouwer, C. D. A., & Schalkwijk, C. G. (2015) · Diabetes · doi:10.2337/db13-1864 · Cited by 156
Self-citationSharma, M. K., Jalewa, J., & Hölscher, C. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12469 · Cited by 151
Metadata
- Authors
- van Eupen, M. G. A., Schram, M. T., Colhoun, H. M., Hanssen, N. M. J., Niessen, H. W. M., Tarnow, L., Parving, H. H., Rossing, P., Stehouwer, C. D. A., & Schalkwijk, C. G.
- Affiliations
- Maastricht University Medical Centre (NL)
- University of Dundee (GB)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Aarhus University (DK)
- University of Copenhagen (DK)
- Corresponding author
- Schalkwijk, C. G.
- ORCID
- Venue
- Diabetologia
- Published
- 2013-04-26
- Volume
- 56
- Issue
- 8
- Pages
- 1845-1855
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2094250911
- Cited by
- 60
- References
- 49
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 3 · 2023: 5 · 2022: 3 · 2021: 4 · 2020: 5 · 2019: 6 · 2018: 6 · 2017: 7 · 2016: 3 · 2015: 8 · 2014: 3 · 2013: 2
- FWCI
- 3.55
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Research Publications (Maastricht University) (acceptedVersion, other-oa)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- British Heart Foundation
- Nierstichting (01C-104)
- Diabetes Fonds (01C-104)
- Center for Translational Molecular Medicine (01 C-104)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Keywords
- methylglyoxal, advanced glycation end products, tetrahydropyrimidines, type 1 diabetes, atherosclerosis, soluble vascular cell adhesion molecule-1, endothelial dysfunction, low-grade inflammation, secretory phospholipase A2, carboxymethyllysine, macroalbuminuria, vascular complications, monoclonal antibodies
- MeSH terms
- Adult, Diabetes Mellitus, Type 1, Enzyme-Linked Immunosorbent Assay, Female, Humans, Immunohistochemistry, Male, Middle Aged, Pyrimidines, Pyruvaldehyde, Glycation End Products, Advanced, Vascular Cell Adhesion Molecule-1, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.